These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24317338)

  • 21. Codominance of cisplatin resistance in somatic cell hybrids.
    Ying YL; Shen DW; Liang XJ; Gottesman MM
    J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells.
    Lee EL; Shimizu T; Ise T; Numata T; Kohno K; Okada Y
    J Cell Physiol; 2007 May; 211(2):513-21. PubMed ID: 17186499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma.
    Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y
    Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between the acquired multi-drug resistance of human large cell lung cancer cell line NCI-H460 by cisplatin selection and p53 mutation].
    Wang T; Xu J; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):102-7. PubMed ID: 15854392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
    An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
    Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells.
    Horibe S; Nagai J; Yumoto R; Tawa R; Takano M
    J Pharm Sci; 2011 Jul; 100(7):3010-7. PubMed ID: 21274848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells.
    Li Q; Peng X; Yang H; Rodriguez JA; Shu Y
    J Pharm Sci; 2012 Jan; 101(1):394-404. PubMed ID: 21905038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
    Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
    To KK; Yu L; Liu S; Fu J; Cho CH
    Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume-sensitive Cl(-) channel as a regulator of acquired cisplatin resistance.
    Shimizu T; Lee EL; Ise T; Okada Y
    Anticancer Res; 2008; 28(1A):75-83. PubMed ID: 18383827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
    Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
    Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
    Gomes CM; van Paassen H; Romeo S; Welling MM; Feitsma RI; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels E; Cleton-Jansen AM
    Nucl Med Biol; 2006 Oct; 33(7):831-40. PubMed ID: 17045162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins.
    Iida T; Kijima H; Urata Y; Goto S; Ihara Y; Oka M; Kohno S; Scanlon KJ; Kondo T
    Cancer Gene Ther; 2001 Oct; 8(10):803-14. PubMed ID: 11687904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
    Kowalski P; Stein U; Scheffer GL; Lage H
    Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.